Ensign Peak Advisors, Inc Qiagen N.V. Transaction History

Ensign Peak Advisors, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$45.29 - $50.76 $47,554 - $53,298	1,050 Added 9.09%	12,600 $578,000
Q4 2022 Feb 13, 2023	BUY	$41.91 - $50.48 $20,955 - $25,240	500 Added 4.52%	11,550 $576,000
Q3 2022 Nov 14, 2022	SELL	$40.9 - $50.42 $67,485 - $83,193	-1,650 Reduced 12.99%	11,050 $540,000
Q3 2021 Nov 12, 2021	SELL	$46.55 - $56.83 $56,558 - $69,048	-1,215 Reduced 8.73%	12,700 $695,000
Q2 2021 Aug 13, 2021	BUY	$46.28 - $52.75 $17,123 - $19,517	370 Added 2.73%	13,915 $691,000

Q1 2021 May 12, 2021	SELL	$46.25 - $56.02 $29,368 - $35,572	-635 Reduced 4.48%	13,545 $677,000
Q4 2020 Feb 12, 2021	BUY	$46.09 - $54.74 $83,192 - $98,805	1,805 Added 14.59%	14,180 $741,000
Q3 2020 Nov 12, 2020	SELL	$42.51 - $52.42 $258,248 - $318,451	-6,075 Reduced 32.93%	12,375 $622,000
Q1 2020 May 11, 2020	SELL	$33.17 - $41.6 $1.1 Million - $1.38 Million	-33,289 Reduced 64.34%	18,450 $758,000
Q4 2019 Feb 14, 2020	BUY	$25.41 - $43.1 $1.31 Million - $2.23 Million	51,739 New	51,739 $1.76 Million

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.16B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.